Tomoya Fukui Selected Research

Tomoya Fukui Research Topics

Disease

27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2006
12	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 11/2007
9	Neoplasms (Cancer) 01/2021 - 03/2010
6	Neoplasm Metastasis (Metastasis) 02/2019 - 05/2007
6	Lung Neoplasms (Lung Cancer) 02/2019 - 05/2007
4	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2019 - 03/2010
4	Adenocarcinoma of Lung 11/2018 - 12/2008
3	Diarrhea 03/2010 - 05/2007
2	Disease Progression 01/2019 - 01/2019
2	Pneumothorax 05/2017 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 04/2011
2	Neutropenia 06/2012 - 05/2007
2	Adenocarcinoma 04/2011 - 11/2007
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Radiation Pneumonitis 01/2020
1	Vomiting 11/2019
1	Nausea 11/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Leukopenia 08/2015
1	Erysipelas 08/2015
1	Infections 08/2015
1	Malaria 03/2015
1	Carcinogenesis 09/2013
1	Inflammation (Inflammations) 09/2013
1	Metaplasia 07/2013
1	Hyperplasia 07/2013
1	Exanthema (Rash) 03/2010
1	Carcinoma (Carcinomatosis) 09/2009
1	Multiple Myeloma 06/2009

Drug/Important Bio-Agent (IBA)

13	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2006
10	amrubicinIBA 01/2021 - 09/2009
7	Tyrosine Kinase InhibitorsIBA 01/2020 - 10/2006
6	Gefitinib (Iressa)FDA Link 03/2010 - 10/2006
5	Irinotecan (Camptosar)FDA LinkGeneric 06/2012 - 05/2007
4	osimertinibIBA 01/2022 - 01/2019
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 10/2006
4	Pharmaceutical PreparationsIBA 12/2020 - 03/2010
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 02/2009
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2019
2	CrizotinibIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 05/2007
2	NivolumabIBA 01/2019 - 11/2018
2	PlatinumIBA 01/2018 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 01/2018 - 01/2018
2	Pemetrexed (MTA)FDA Link 05/2017 - 01/2016
2	Biological ProductsIBA 11/2013 - 09/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	alectinibIBA 01/2021
1	AfatinibIBA 12/2020
1	AntibodiesIBA 11/2020
1	PerforinIBA 11/2020
1	durvalumabIBA 01/2020
1	ProdrugsIBA 11/2019
1	Neurokinin-1 Receptor AntagonistsIBA 11/2019
1	Palonosetron (Aloxi)FDA Link 11/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 11/2018
1	B7-H1 AntigenIBA 11/2018
1	Hormones (Hormone)IBA 05/2018
1	AsbestosIBA 01/2018
1	nedaplatinIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	CollagenIBA 01/2018
1	Folic Acid AntagonistsIBA 05/2017
1	pazopanib FDA Link 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	SodiumIBA 03/2016
1	Chloroquine (Aralen)FDA LinkGeneric 03/2015
1	CytokinesIBA 09/2013
1	SecretoglobinsIBA 07/2013
1	Type 1 Angiotensin ReceptorIBA 02/2013
1	P-SelectinIBA 02/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013
1	Angiotensin IIIBA 02/2013
1	Topoisomerase I InhibitorsIBA 06/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2012
1	Topoisomerase II InhibitorsIBA 06/2012
1	SmokeIBA 04/2011
1	CathepsinsIBA 04/2011
1	Cystatin AIBA 04/2011
1	Phosphotransferases (Kinase)IBA 03/2010
1	Warfarin (Coumadin)FDA LinkGeneric 08/2009
1	GlucocorticoidsIBA 06/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2009
1	GlucuronidaseIBA 10/2008

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2020 - 02/2009
9	Therapeutics 01/2021 - 12/2008
2	Chemoradiotherapy 01/2020 - 07/2017
1	Drug Tapering 12/2020
1	Immunotherapy 11/2020
1	Intravenous Administration 11/2019
1	Cranial Irradiation 01/2018
1	Radiotherapy 03/2016
1	Combined Modality Therapy 03/2016
1	Palliative Care (Palliative Therapy) 06/2014